TriSalus Life Sciences, Inc. (TLSI) Shareholders’ equity 2022–2025
TriSalus Life Sciences, Inc. (TLSI) shareholders’ equity at each fiscal year-end, per SEC filings.
-$33.9MFY2025 · since FY2022: -$177.1M → -$33.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.9M | -30.8% |
| FY2024 | -$25.9M | +4.3% |
| FY2023 | -$27.1M | +84.7% |
| FY2022 | -$177.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice